depolarization process during the diastolic phase of the cardiac cycle. This is due to hyperpolarizationactivated cyclic nucleotide-gated (HCN) channels, which are responsible for providing an inward current. Genetically engineered mesenchymal stem cells (MSCs) were transfected with hHCN4 genes using lentiviral transfection, and their potential use as biological pacemaker cells was investigated. In addition to expressing an anticipated high level of the hHCN4 gene, MSCs transfected with hHCN4 genes also expressed characteristic hHCN4 protein, a cardiac pacemaker-like current and were capable of increasing the spontaneous beating rate of co-cultured cardiac myocytes. Control MSCs did not exert these effects. It is hypothesized that genetically engineered MSCs transfected with hHCN4 genes by lentiviral transfection can be modified to be cardiac pacemaker cells in vitro.
Introduction
The implantation of electronic pacemakers is the preferred treatment for symptomatic bradyarrhythmias. Although providing excellent success and minimal morbidity, such devices have many disadvantages including limited battery life, the need for lead implantation into the heart which in most cases cannot be removed, and the lack of response to autonomic and physiological demands on the heart. Furthermore, such devices cannot follow the somatic growth of young patients, so they have to be changed as a child grows. 1 For these reasons, the development of a biological pacemaker has been explored as a possible alternative.
Pacemaker cells differ from common cardiomyocytes due to the presence of a spontaneous depolarization process during the diastolic phase of the cardiac cycle. This is the result of hyperpolarization-activated cyclic nucleotide-gated channel (HCN) genes, which code for specific proteins that are capable of providing an inward current. In this paper, genetically engineered mesenchymal stem cells (MSCs) were transfected with human HCN4 (hHCN4) genes using lentiviral transfection, and their
Materials and methods

MSC PREPARATION
The MSCs were isolated from rabbits as previously described. 2 Briefly, a bone marrow aspirate was collected from the posterior iliac crest into a syringe containing 6000 IU heparin. The marrow sample was washed with phosphate buffered saline (PBS; 10 mM, pH 7.4) and the cells were recovered after centrifugation at 900 g. Nucleated cells were counted and 1 × 10 8 nucleated cells were loaded onto 25 ml of 1.073 g/ml Percoll ® solution (KangChen Bio-tech, Shanghai, China) in a 50 ml conical tube. Cells were then centrifuged at 1100 g for 30 min at 20°C. The nucleated cells were then collected from the upper layer and interface, diluted with two volumes of PBS and collected by centrifugation at 900 g. The cells were cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO 2 . Cells from passages 2 -4 were used.
The experiments were completed according to the guidelines of Soochow University for the care and use of animals in laboratory experiments. Ethical approval for the study was granted by the ethical committee of Soochow University.
LENTIVIRAL VECTOR-MEDIATED, STABLE GENETIC MODIFICATION OF MSCS
For stable genetic modification, selfinactivating human immunodeficiency virus (HIV)-1-based lentiviral vector (LentiV) was used for transgene delivery. 3 The LentiV-hHCN4-green fluorescent protein (GFP) was constructed with plasmid hHCN4/pcDNA3 by KangChen Bio-tech.
MSCs were transduced by adding purified LentiV to cells at a final concentration of 10 000 transducing units/ml, with 8 µg/ml polybrene to facilitate transduction, for 12 -16 h. The multiplicity of infection was two for each round of transduction. Green portions of the MSC colonies were microsurgically segregated from the nongreen cells, followed by culturing under nondifferentiating conditions for expansion. 3
RT-PCR ANALYSIS
Total RNA was extracted from control MSCs and those transfected with hHCN4. Reverse transcription-polymerase chain reaction (RT-PCR) was performed as previously described. 4 The PCR was performed for 40 cycles, with each cycle consisting of denaturation at 95°C, annealing at 55°C and amplification at 72°C for 1 min. The PCR primers used were nest forward hHCN4: GACGGCTCCTACTTTGG, and nest reverse hHCN4: GGTGGGTGAGGGCTAT. Densitometric analysis was applied to quantify the mRNA levels.
WESTERN BLOT ANALYSIS
Membrane proteins were extracted from control and hHCN4-transfected MSCs. A total of 50 mg protein per lane was run on an 8% sodium dodecylsulphate-polyacrylamide gel electrophoresis system then electroblotted onto nitrocellulose filters. Polyclonal antibodies to hHCN4 were purchased from Alpha Diagnostic International (San Antonio, TX, USA). Western blot analysis was performed as described previously. 5
PATCH-CLAMP STUDIES OF CARDIAC PACEMAKER CURRENT EXPRESSED IN MSCS
Whole-cell patch clamp was used to study membrane currents in control MSCs and those transfected with hHCN4. Expressed
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cardiac pacemaker current, I f (i.e. I HCN4 ), was measured under voltage clamp by an Axopatch-200B amplifier (Axon Instruments [Molecular Devices], Sunnyvale, CA, USA). Patch electrode resistance was 3 -5 MΩ before sealing. The cells were constantly superfused using a gravitational perfusion system, with a complete change of the chamber solutions in about 0.5 min. The pipette solution was 6 mmol/l sodium chloride, 130 mmol/l potassium aspartate, 2 mmol/l magnesium chloride, 2 mmol/l calcium chloride, 2 mmol/l disodium adenosine triphosphate, 5 mmol/l ethylene glycol tetra-acetic acid, 0.1 mmol/l sodium guanosine triphosphate, 0.2 mmol/l cyclic adenosine monophosphate and 5 mmol/l HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid) (pH adjusted to 7.2 with potassium hydroxide). The external solution contained 137.7 mmol/l sodium chloride, 5.4 mmol/l potassium chloride, 2.3 mmol/l sodium hydroxide, 1.8 mmol/l calcium chloride, 1 mmol/l magnesium chloride, 10 mmol/l glucose, 5 mmol/l HEPES, 2 mmol/l barium chloride, 2 mmol/l 4-aminopyridine and 2 mmol/l cadmium chloride (pH adjusted to 7.4 with sodium hydroxide). Values of I f were elicited in the whole cell configuration by holding the cells at -40 mV for 50 ms followed by hyperpolarizing incremental steps of 10 mV at 2 s intervals to -140 mV, and then returning to -40 mV for 50 ms. After the I f was recorded, the cells were superfused with extracellular solution containing 4 mM caesium chloride and the currents were measured accordingly.
MSCS CO-CULTURED WITH CARDIAC MYOCYTES
To test whether the MSCs coupled electrically with cardiac myocytes, co-cultured MSCs were transfected with either GFP alone or GFP-hHCN4 with neonatal rabbit ventricular myocytes prepared as described previously. 6 Myocytes were dissociated and plated for 48 h before co-culture with MSCs. The coculture beating rate for the cardiac myocytes was measured after 3 days of co-culture.
STATISTICAL ANALYSIS
Data (beats/min) were presented as means ± SD calculated from the number (n) of experiments carried out. Statistical differences were determined by Student's unpaired t-test and P < 0.05 was considered statistically significant.
Results
GENE AND PROTEIN EXPRESSIONS OF HHCN4-TRANSFECTED MSCS
The expression of hHCN4 genes and protein, measured by real-time RT-PCR and Western blot analysis, indicates a unique profile of hHCN4-transfected MSCs. In addition to expressing the anticipated high level of the hHCN4 gene ( Fig. 1) , hHCN4-transfected MSCs also expressed characteristic hHCN4 protein (Fig. 2) . A GFP immunofluorescence image, indicating positive MSCs transfected with the hHCN4 gene, is shown in Fig. 3 . Control MSCs were negative. The hHCN4 Western blot and RT-PCR bands show comparable levels of expression for the protein and gene, suggesting a similar degree of efficiency of the cell transcription/translation machinery for the clones.
ELECTROPHYSIOLOGY OF MSCS TRANSFECTED WITH HHCN4
An important characteristic of a cardiac pacemaking myocyte is the expression of an inward I f . 7 The I f was voltage-dependent and the voltage threshold for activation of I f was approximately -80 mV (Fig. 4A ). All the hHCN4 positive cells exhibited a large
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caesium-sensitive I f that was inhibited by 4 mM caesium chloride (Fig. 4B ) thereby confirming that this current was the I f . 8
BEATING RATE OF CARDIAC MYOCYTES CO-CULTURED WITH MSCS
It was hypothesized that the hHCN4transfected MSCs could influence the excitability of coupled cardiac myocytes. The co-culture rate of cardiac myocytes was 86 ± 12 beats/min when MSCs were transfected with control plasmid (expressing only GFP) and 155 ± 21 beats/min when MSCs were expressing both GFP and hHCN4 (n = 10, P < 0.05).
Discussion
Pacemaker implantation is a primary treatment for complete heart block or sinus node dysfunction. Nevertheless, such devices lack the biological response of native tissues. As a result several approaches have been attempted to provide biological pacemaker function and local over-expression of the HCN4 gene -the molecular correlate of the endogenous cardiac pacemaker current in the cardiomyocytes -is one novel approach. Pacemaker cells differ from common 
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cardiomyocytes due to the presence of a spontaneous depolarization process, which progressively reduces the membrane potential during the diastolic phase of the cardiac cycle. When the reduction reaches a critical threshold value, the sodium channels open and the action potential is generated.
The spontaneous diastolic depolarization of the pacemaker cells is the result of the expression of HCN genes, which code for specific proteins that are capable of providing an inward current named I f . The main difference, therefore, between pacemaker cells and other cardiomyocytes depends only upon which genes are fully expressed. 9 Hence, we hypothesized that genetically engineered MSCs transfected with hHCN4 genes can be modified to become cardiac pacemaker cells.
The MSCs are an attractive cellular vehicle for gene delivery applications. They can be obtained in relatively large numbers through a standard clinical procedure, are easily expanded in culture and are capable of long-term transgene expression. 10 Their administration can be autologous or via banked stores, giving evidence that they may be immunopriviliged. 11 The long-term function of such a pacemaker would be based on the prolonged expression of hHCN4 which, in turn, would require integration into the genome of MSCs. In addition to expressing characteristic hHCN4 protein, the hHCN4-transfected MSCs in the present study Mesenchymal stem cells as a gene delivery system also expressed an anticipated high level of the hHCN4 gene, produced an I f -like current and were capable of increasing the spontaneous beating rate of co-cultured cardiac myocytes; control MSCs expressing only GFP did not exert these effects. Thus, the electrical effects of the MSCs transfected with the hHCN4 gene were similar to the effects of over-expression of the same gene in the myocyte in vitro system.
These findings suggest that MSCs may serve as an alternative approach for the delivery of pacemaker genes for cardiac implantation. In sinus node myocytes the HCN gene is responsible for the inward current necessary for cardiac excitation. 7 Unlike sinoatrial node cells, hHCN4transfected MSCs are not excitable because they lack the other currents required to generate an action potential. However, these cells are able to generate a depolarizing current which spreads to coupled myocytes, driving the myocytes to the threshold voltage. It is hypothesized that, as long as the MSCs contain the pacemaker gene and couple to cardiac myocytes via gap junctions, they will function as a cardiac pacemaker in an analogous manner to the normal primary pacemaker in the sinoatrial node.
Before hHCN4-transfected MSCs can be applied clinically, many issues need to be resolved. A major one is the duration of efficacy of the pacemaker cells. The duration of pacemaker function in approaches using viruses depends on how long the viruses and resulting protein constructs survive in the host. To ensure long-term function, an appropriate delivery system, in which the construct is effective for long periods, must be identified. For stable genetic modification, the present study used LentiV for transgene delivery because, unlike adenoviruses, it allows persistent transgene expression without eliciting host immune responses. 3 Expression of the gene in the present study persisted, however it has lasted no more than 3 months in previous studies where other virus vectors were used for transgene delivery. 12 These unique properties make LentiV ideal for modifying MSCs.
In conclusion, MSCs transfected with hHCN4 genes by LentiV expressed characteristic hHCN4 protein, produced an I flike current and were capable of increasing the spontaneous beating rate of co-cultured cardiac myocytes. This study suggests that genetically engineered MSCs transfected with hHCN4 genes by lentiviral transfection can be modified to be cardiac pacemaker cells in vitro.
